Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity

The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the immunogenicity and clinical utility of recombinant Ad5 (rAd5) vector-based vaccines for human immunodeficiency virus type 1 and other pathogens. A potential solution to this problem...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lemckert, Angelique A. C., Sumida, Shawn M., Holterman, Lennart, Vogels, Ronald, Truitt, Diana M., Lynch, Diana M., Nanda, Anjali, Ewald, Bonnie A., Gorgone, Darci A., Lifton, Michelle A., Goudsmit, Jaap, Havenga, Menzo J. E., Barouch, Dan H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Pathogenesis and Immunity
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1181575/
https://ncbi.nlm.nih.gov/pubmed/16014931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.15.9694-9701.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados